Vision Executives Blog

Sightpath Medical Acquires LASIK Provider PennVista

Written by Vision Executives | Jul 5, 2024 12:02:25 PM

๐’๐ข๐ ๐ก๐ญ๐ฉ๐š๐ญ๐ก ๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐€๐œ๐ช๐ฎ๐ข๐ซ๐ž๐ฌ ๐‹๐€๐’๐ˆ๐Š ๐๐ซ๐จ๐ฏ๐ข๐๐ž๐ซ ๐๐ž๐ง๐ง๐•๐ข๐ฌ๐ญ๐š

๐Ÿค Sightpath Medical has officially acquired PennVista, a prominent provider of laser-assisted in situ keratomileusis (LASIK) services across multiple states. This strategic purchase aims to expand Sightpath Medicalโ€™s presence in key markets and bolster its efforts to support ophthalmic practices nationwide.

๐Ÿ‘ โ€œThis transaction, coupled with our recent LASIK Doctor Network Project, underscores our commitment to helping comprehensive ophthalmology practices successfully offer LASIK to their patientsโ€, stated Joel Gaslin, President and CEO of Sightpath Medical.

๐ŸŒŽ With the acquisition, which was finalised on May 30, 2024, Sightpath Medical will now be able to provide a broader range of services and resourced to more practices across the United States. This move enhances their ability to assist ophthalmologists in delivering high-quality LASIK procedures to patients.